Babesiosis
Basics
- Caused by intraerythrocytic protozoan Babesia species.
- Geographic distribution mainly Northeastern and upper Midwest U.S.; sporadic global cases.
- Incubation: 5-33 days, up to 9 weeks post-transfusion.
- Systems affected: cardiovascular, GI, hemic/lymphatic/immunologic, musculoskeletal, nervous, pulmonary, renal.
- Pediatric, pregnancy, and geriatric considerations noted.
Epidemiology
- Most patients in 40s-50s.
- Coinfection with other tick-borne diseases common (Lyme, ehrlichiosis).
- Approx. 2,000 cases/year reported to CDC (2020 data).
- Prevalence hard to estimate due to asymptomatic cases.
Etiology & Pathophysiology
- Main agents: B. microti (US), B. divergens, B. bovis (Europe), B. duncani (US).
- Vectors: Ixodes dammini/scapularis (deer tick), Ixodes ricinus.
- Reservoir: white-footed deer mouse.
- Infection via tick saliva; sporozoites infect RBCs causing hemolysis.
- Humans are dead-end hosts.
Risk Factors
- Residence in endemic areas.
- Asplenia, immunosuppression, advanced age.
Prevention
- Avoid endemic areas May-September.
- Use insect repellents with DEET (10-35%) and permethrin-treated clothing.
- Daily tick checks.
Associated Conditions
- Coinfection with Borrelia burgdorferi and Ehrlichia spp.
Diagnosis
History
- Travel or residence in endemic areas.
- Symptoms similar to malaria: fever, fatigue, chills, sweats, headache, myalgia, anorexia, cough, arthralgia, nausea.
- Severe disease in comorbid patients.
Physical Exam
- High fever, hemodynamic instability possible.
- Mild hepatosplenomegaly.
- Rare rash; consider Lyme disease if rash present.
- CNS involvement: headache, photophobia, neck stiffness, altered sensorium.
- Jaundice, dark urine late.
Differential Diagnosis
- Bacterial sepsis, hepatitis, Lyme disease, ehrlichiosis, Rocky Mountain spotted fever.
- Malaria, HIV, EBV, HELLP syndrome (pregnancy).
Tests
- Labs: hemolytic anemia, elevated LDH, mild leukopenia, elevated transaminases, renal dysfunction.
- Blood smear (Wright/Giemsa): intraerythrocytic parasites, pathognomonic Maltese cross tetrads.
- Serology: IgM by IFAT; titers >1:64 or 4-fold rise diagnostic.
- PCR: highly sensitive/specific; useful for monitoring.
- Animal inoculation in refractory diagnosis.
Treatment
General Measures
- Empiric doxycycline in endemic areas to cover coinfections until testing complete.
- Treat asymptomatic patients only if parasitemia >3 months.
Medications
- First line (mild-moderate): atovaquone 750 mg PO BID (with fatty meal) + azithromycin (loading 500 mg BID day 1, then 250 mg daily).
- Pediatrics: weight-based dosing of above agents.
- Severe disease: IV azithromycin and atovaquone or oral quinine plus IV clindamycin.
- Persistent/relapsing: 6-week course, 2 weeks after negative smear.
- Second line: quinine + clindamycin (preferred for severe cases).
- Other agents (tetracycline, primaquine, sulfadiazine) less consistent efficacy.
Alerts
- Clindamycin may cause C. difficile colitis.
Referral
- Infectious disease and hematology consult for severe disease and exchange transfusion consideration (parasitemia >10%, asplenia, massive hemolysis).
Admission
- Severe babesiosis with organ compromise.
- Exchange transfusion for high parasite load or critical illness.
Follow-Up
- Monitor parasitemia and hematocrit until clinical and parasitological resolution.
- Mild/moderate disease improves in 48 hours; full resolution by 3 months.
- Risk factors for severity: ALP >125 U/L, WBC >5x10^9/L, cardiac abnormality, splenectomy, murmur, parasitemia β₯4%.
Complications
- CHF, DIC, ARDS, renal failure, coma, death.
- Warm autoimmune hemolytic anemia in asplenic patients.
Clinical Pearls
- Tick must be attached >24 hours for transmission.
- Most patients unaware of tick bite.
- First-line treatment: atovaquone plus azithromycin.
- Coinfection with Lyme and ehrlichiosis common; doxycycline covers these.
- Untreated infections may persist silently for months or years.